StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)

Close on Nov 18, 2026Market cap $466.86MP/E –Yield –

Capricor Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Capricor Therapeutics's pe ratio was 41.9× on Jan 31, 2019, against 160.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201941.9×+8.2
2018Dec 31, 201833.7×−126.3
2013Jan 31, 2013160.0×+93.3
2012Dec 31, 201266.7×−201.1
2011Dec 30, 2011267.7×–

More Capricor Therapeutics figures

See a number that looks wrong?